Healthcare / Health Information ServicesNasdaqCM
$0.88
+0.01 (+1.03%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-14.6M · quality 52.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
4/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$49M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-807.3%
↓Gross Margin
N/A
•Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2020–2025 · 5 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
0.69x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $-21.0M · FCF $-14.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Net Income | $-21.0M | $-21.0M | $-19.4M | $-14.6M | $-13.0M | $-4.4M | $-1.1M |
| EBITDA | $-21.1M | $-21.1M | $-19.9M | $-15.3M | $-13.0M | — | — |
| EPS | — | — | -0.73 | -0.72 | -1.59 | -1.03 | -0.29 |
| Balance Sheet | |||||||
| Current Ratio | 0.74 | 0.74 | — | — | — | — | — |
| Cash Flow | |||||||
| Free Cash Flow | $-14.6M | $-14.6M | $-14.7M | $-12.3M | $-9.9M | — | — |
| Returns | |||||||
| ROE | -807.3% | -807.3% | -1175.8% | -91.9% | -546.0% | -33.0% | 22.3% |
| Valuation | |||||||
| P/B | 13.62 | 13.62 | 36.09 | 2.83 | 14.55 | — | — |
| Growth & Yield | |||||||
| EPS Growth | — | — | -1.4% | 54.7% | — | -255.2% | — |
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-48.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.73 → n/d
Residual
-48.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.